ResearcherGenomics Research Center, Academia SinicaActive in the last 2 years

Wei‐Chieh Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9319-3010; OpenAlex author ID A5035371907. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy. Last author DOI 10.1016/j.biopha.2025.117892 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sui-Chih Tien · 1 shared paper, 2025 · strength 0.23
- Paper Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy. DOI 10.1016/j.biopha.2025.117892 ↗
Chun‐Mei Hu · 1 shared paper, 2025 · strength 0.23
- Paper Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy. DOI 10.1016/j.biopha.2025.117892 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.